Handelsavisen
prelaunch
Companies Healthcare 4175.TWO
41
4175.TWO TPEx Medical Equipment, Supplies & Distribution

MedFirst Healthcare Services Inc

$53,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
2,94 %
Op margin
0,5 %
ROE
-0,2 %
Net margin
-0,1 %
Debt / equity
2,70
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

MedFirst Healthcare Services Inc provides medical equipment, supplies, and distribution services in the healthcare sector, generating revenue primarily through the sale and distribution of medical products and services.

Business. MedFirst Healthcare Services Inc (4175.TWO) operates in the Medical Equipment, Supplies & Distribution industry within the broader Healthcare Services & Equipment sector. The company is listed on the Taiwan Premium Exchange (TPEx). Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-0,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 4175.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 4175.TWO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    MedFirst Healthcare Services Inc (4175.TWO) operates in the Medical Equipment, Supplies & Distribution industry within the broader Healthcare Services & Equipment sector. The company is listed on the Taiwan Premium Exchange (TPEx). Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    MedFirst Healthcare Services Inc has a liquidity position that is below the industry median, with a current ratio of 0.76, indicating that the company's current assets are insufficient to cover its current liabilities. The company's liquidity_fpt score is also below the industry median, suggesting a medium liquidity risk. The company's cash and equivalents amount to 41,876,000 TWD, which is significantly lower than its long-term debt of 3,921,419,000 TWD, further highlighting the liquidity constraints.

    The company's profitability is weak, with a net income of -2,417,000 TWD and a return on equity of -0.0017, both of which are below the industry median. The operating income of 8,381,000 TWD is also below the industry median, indicating that the company is not generating sufficient operating profits to support its equity base. The return on assets of -0.0003 further underscores the inefficiency in asset utilization.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the risk of revenue concentration, as the company's performance is heavily dependent on a single segment. The absence of detailed segment data makes it difficult to assess the company's exposure to different markets or product lines.

    The company's growth trajectory is mixed, with a revenue of 1,836,693,000 TWD in the latest period. The outlook for the current fiscal year is uncertain, with no significant growth expected. The company's capital expenditure of -31,462,000 TWD indicates a reduction in investment, which may affect future growth potential. The free cash flow of 111,380,000 TWD is positive but insufficient to cover the company's debt obligations.

    The company faces several risk factors, including a high debt-to-equity ratio of 2.7, which is significantly above the industry median. The liquidity risk is medium, and the company's net cash is negative after subtracting total debt, indicating a potential cash flow problem. The dilution risk is low, with no significant dilution expected in the near term. The company has not made any recent significant announcements or filings that would indicate a change in its risk profile.

    Recent events and filings do not indicate any major changes in the company's operations or financial position. The company's last actual EPS was 3.64 TWD, and the last actual revenue was 8,012,666,000 TWD, according to analyst estimates. There are no recent transcripts or filings that suggest a significant shift in the company's strategy or performance.

    Key takeaways
    • MedFirst Healthcare Services Inc has a weak profitability profile, with a negative net income and return on equity below the industry median.
    • The company's liquidity position is constrained, with a current ratio of 0.76 and a high debt-to-equity ratio of 2.7.
    • Revenue is concentrated in a single business segment, increasing the risk of revenue concentration.
    • The company's growth trajectory is uncertain, with no significant growth expected in the current fiscal year.
    • The company faces medium liquidity risk and a potential cash flow problem due to its high debt obligations.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Free cash flow surged 345.7% year-over-year to TWD 454.7 million, demonstrating significant improvement in cash generation capabilities.

    Revenue grew 18.3% year-over-year, indicating strong top-line expansion momentum despite recent volatility in net income figures.

    Long-term debt decreased to TWD 3.58 billion in FY2026, suggesting a strategic reduction in leverage over the forecast period.

    Gross profit expanded to TWD 2.6 billion in FY2026, reflecting improved core profitability before operating expenses are deducted.

    Operating income is projected to reach TWD 211.3 million in FY2026, signaling a recovery in operational efficiency.

    BEAR CASE · 4

    The debt-to-equity ratio of 2.7 places the company in the bottom quartile, indicating excessive leverage compared to peers.

    Net margin of -0.13% falls significantly below the cohort median of 2.21%, highlighting severe profitability challenges relative to competitors.

    Return on equity of -0.17% is well below the cohort median of 1.42%, demonstrating poor capital efficiency for shareholders.

    High credit risk flags suggest potential difficulties in meeting financial obligations, exacerbated by the company's heavy debt load.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-03-31
    Q4 2025 · Quarter highlights

    Revenue TWD 2.11B, +3,3% YoY; Operating income −19,4% YoY.

    RevenueTWD 2.11B+3,3 % YoY
    Operating incomeTWD 63.0M−19,4 % YoY
    Net incomeTWD 52.1M−12,6 % YoY
    Free cash flowTWD 186.2M+1,7 % YoY
    EPS
    Operating cash flowTWD 904.0M+66,7 % YoY
    Financials
    Income statement
    RevenueTWD 2.11B
    Gross profitTWD 681.7M
    Operating incomeTWD 63.0M
    Net incomeTWD 52.1M
    Margins
    Gross margin32.2%
    Operating margin3.0%
    Net margin2.5%
    FCF margin8.8%
    Balance sheet
    Total assetsTWD 7.28B
    Total liabilitiesTWD 5.72B
    Total equityTWD 1.56B
    Cash & equivalentsTWD 66.1M
    Long-term debtTWD 3.58B
    Cash flow
    Operating cash flowTWD 904.0M
    CapEx-TWD 279.6M
    Free cash flowTWD 186.2M
    SBC
    P&L flow · revenue → net income
    Revenue TWD 2.11BOperating costs TWD 2.05BTax TWD 10.9MNet income TWD 52.1M
    Highlights
    • Revenue TWD 2.11B, +3,3% YoY
    • Operating income −19,4% YoY
    • Net income −12,6% YoY
    • Free cash flow +1,7% YoY
    • Net margin 2.5%

    Valuation TTM

    Market price
    $53,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $1.45B
    Net cash
    -$3.88B
    Current ratio
    0.8
    Debt / equity
    2.7
    ROA
    -0.0%
    ROE
    -0.2%
    Cash conversion
    -1309.0%
    CapEx / revenue
    -1.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin0,5 %Below median
    Net Margin-0,1 %Below median
    ROE-0,2 %Below median
    Capex / Rev-1,7 %Above P75
    D/E2,70Bottom quartile
    Cash Conv-13,09Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • MedFirst Healthcare Services Inc Market data — financials · 2026-05-26
    • MedFirst Healthcare Services Inc Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    4175.TWOCanonical
    TPEx · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-03-31 19:42 UTCEARNINGSQuarterly results — Q4 2025 Revenue TWD 2.11B · Net TWD 52.1M
    2026-03-31 19:42 UTCEARNINGSAnnual results — FY 2026 Revenue TWD 8.01B · Net TWD 155.5M
    2025-11-10 14:11 UTCEARNINGSQuarterly results — Q3 2025 Revenue TWD 1.99B · Net TWD 31.1M
    2025-08-07 13:17 UTCEARNINGSQuarterly results — Q2 2025 Revenue TWD 2.01B · Net TWD 28.6M
    2025-05-08 13:45 UTCEARNINGSQuarterly results — Q1 2025 Revenue TWD 1.90B · Net TWD 43.7M
    2024-03-12 15:04 UTCEARNINGSAnnual results — FY 2024 Revenue TWD 7.45B · Net TWD 46.8M
    2023-02-23 16:46 UTCEARNINGSAnnual results — FY 2023 Revenue TWD 7.22B · Net TWD 170.9M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage